Nevertheless, the repeated measurements of parameters and the larger cohort of patients used in this study provided novel evidence of the impact of MTHFR C677 polymorphisms on antipsychotic-induced metabolic syndromes, which contributes to the understanding of antipsychotic side effects and decision of antipsychotic treatment in the clinic. This evidence concerns the gene MTHFR and metabolic syndrome.